Ginkgo Bioworks Holdings Inc-A 2026年季度报告

FORM 10-Q______________________________________________ (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from _________________ to _________________Commission File Number: 001-40097 GINKGO BIOWORKS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction ofincorporation or organization) Registrant’s telephone number, including area code: (877) 422-5362 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subjectto such filing requirements for the past 90 days.YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files).YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. As of April30, 2026, the registrant had 53,361,141 shares of Class A common stock, 8,963,350 shares of Class B common stock, and3,000,000 shares of non-voting Class C common stock outstanding. Cautionary Note Regarding Forward-Looking Statements This report includes forward-looking statements regarding, among other things, the plans, strategies and prospects, both business andfinancial, of Ginkgo Bioworks Holdings, Inc. (“Ginkgo” or the “Company”). These statements are based on the beliefs andassumptions of the management of Ginkgo. Although Ginkgo believes that its plans, intentions and expectations reflected in orsuggested by these forward-looking statements are reasonable, Ginkgo cannot assure you that it will achieve or realize these plans,intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally,statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, eventsor results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words“believes”, “estimates”, “expects”, “projects”, “forecasts”, “may”, “will”, “should”, “seeks”, “plans”, “scheduled”, “anticipates” or“intends” or similar expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are notlimited to, statements about: •Ginkgo’s ability to raise additional capital in the future; •factors relating to the business, operations and financial performance of Ginkgo, including: ◦Ginkgo’s ability to develop and expand its offerings;◦the performance and output of Ginkgo’s offerings;◦Ginkgo’s ability to effectively manage its organizational changes, including its restructuring actions commenced in2024, and related impacts on Ginkgo’s financial performance;◦Ginkgo’s expectations regarding research and development (“R&D”), general and administrative (“G&A”) andrestructuring expenses;◦Ginkgo’s exposure to the volatility and liquidity risks inherent in holding equity interests in certain of its customers;◦the scope and timing of Ginkgo’s partnerships around the world;◦the acquisition and integration of companies, assets or intellectual property that advance Ginkgo’s objectives and thecosts required to maintain, expand and protect Ginkgo’s intellectual property; and◦the Company’s beliefs regarding the sufficiency of its existing cash, cash equivalents and marketable securities tofund its operations. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from thoseexpressed or implied by such forward-looking statements. Applicable risks and uncertainties include, among others: •intense competition and competitive pressures from other companies worldwide in the industries in which Ginkgo operates;•litigation, including securities or shareholder litigation, and the ability to adequately protect Ginkgo’s intellectual propertyrights;•rapidly changing te